img

Global Japanese Encephalitis Virus Vaccine Market Insights, Forecast to 2034

Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Japanese Encephalitis Virus Vaccine Market Insights, Forecast to 2034

Japanese Encephalitis vaccine info for parents, public, and healthcare professionals.
Global Japanese Encephalitis Virus Vaccine market is expected to reach to US$ 420.9 million in 2024, with a positive growth of %, compared with US$ 408.6 million in 2022 which suffered dual impact of COVID-19 and Russia-Ukraine War in the year. Backed with the increasing demand from downstream industries, Japanese Encephalitis Virus Vaccine industry is evaluated to reach US$ 572.2 million in 2029. The CAGR will be 5.3% during 2024 to 2029.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Covers
This report presents an overview of global Japanese Encephalitis Virus Vaccine market from 2018 to 2029, aiming to help readers to get a comprehensive understanding of global Japanese Encephalitis Virus Vaccine market with multiple angles. Items like regional sales, revenue from 2018 to 2029 and manufacturers’ sales, price, revenue and gross margin from 2018 to 2024 are analyzed. In addition, sales and revenue of product type and application in each region from 2018 to 2029 are also highlighted.
Manufacturers, Type, Application and Regions Listed in the Report



By Company


Research Foundation for Microbial Diseases of Osaka University
Valneva Austria GmbH
Chengdu Institute
Liaoning Dacheng
Wuhan Institute
Segment by Type
Inactivated Vaccine
Live Attenuated Vaccine

Segment by Application


Public
Private

Segment by Region


US & Canada
U.S.
Canada
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Europe
Germany
France
UK
Italy
Russia
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries

Chapter Outline


Chapter 1Product definition, type and application introduction
Chapter 2Regional revenue and sales volume analysis from 2018 to 2029
Chapter 3Manufacturers’ sales, revenue and price analysis, including manufacturers’ Japanese Encephalitis Virus Vaccine plant distribution, commercial date of Japanese Encephalitis Virus Vaccine, product type offered, Mergers & Acquisitions and expansion activities.
Chapter 4Product sales, revenue and price analysis by type from 2018 to 2029 globally
Chapter 5Product sales, revenue and price analysis by application from 2018 to 2029 globally
Chapter 6Product sales, revenue analysis by type and application from 2018 to 2029 in US & Canada. Product sales and revenue analysis of each country in US & Canada from 2018 to 2029
Chapter 7Product sales, revenue analysis by type and application from 2018 to 2029 in Europe. Product sales and revenue analysis of each country in Europe from 2018 to 2029
Chapter 8Product sales, revenue analysis by type and application from 2018 to 2029 in China. Product sales and revenue analysis of China from 2018 to 2029
Chapter 9Product sales, revenue analysis by type and application from 2018 to 2029 in Asia (excluding China). Product sales and revenue analysis of each country in Asia (excluding China) from 2018 to 2029
Chapter 10Product sales, revenue analysis by type and application from 2018 to 2029 in Middle East, Africa and Latin America. Product sales and revenue analysis of each country in Middle East, Africa and Latin America from 2018 to 2029.
Chapter 11Manufacturers’ outline, covering company’s basic information, major business, Japanese Encephalitis Virus Vaccine introduction, etc. Japanese Encephalitis Virus Vaccine Sales, Revenue, Price and Gross Margin of each company from 2018 to 2024
Chapter 12Industry chain analysis, like raw materials, manufacturing cost. Market channel, distributors and customers analysis
Chapter 13Market opportunities and challenges analysis
Chapter 14Mr Accuracy reports’s Conclusions of Japanese Encephalitis Virus Vaccine
Chapter 15Methodology and Data Sources adopted by Mr Accuracy reports

Table of Content

1 Study Coverage
1.1 Japanese Encephalitis Virus Vaccine Product Introduction
1.2 Market by Type
1.2.1 Global Japanese Encephalitis Virus Vaccine Market Size Growth Rate by Type, 2018 VS 2022 VS 2029
1.2.2 Inactivated Vaccine
1.2.3 Live Attenuated Vaccine
1.3 Market by Application
1.3.1 Global Japanese Encephalitis Virus Vaccine Market Size Growth Rate by Application, 2018 VS 2022 VS 2029
1.3.2 Public
1.3.3 Private
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Japanese Encephalitis Virus Vaccine Sales Estimates and Forecasts 2018-2029
2.2 Global Japanese Encephalitis Virus Vaccine Revenue by Region
2.2.1 Global Japanese Encephalitis Virus Vaccine Revenue by Region: 2018 VS 2022 VS 2029
2.2.2 Global Japanese Encephalitis Virus Vaccine Revenue by Region (2018-2024)
2.2.3 Global Japanese Encephalitis Virus Vaccine Revenue by Region (2024-2029)
2.2.4 Global Japanese Encephalitis Virus Vaccine Revenue Market Share by Region (2018-2029)
2.3 Global Japanese Encephalitis Virus Vaccine Sales Estimates and Forecasts 2018-2029
2.4 Global Japanese Encephalitis Virus Vaccine Sales by Region
2.4.1 Global Japanese Encephalitis Virus Vaccine Sales by Region: 2018 VS 2022 VS 2029
2.4.2 Global Japanese Encephalitis Virus Vaccine Sales by Region (2018-2024)
2.4.3 Global Japanese Encephalitis Virus Vaccine Sales by Region (2024-2029)
2.4.4 Global Japanese Encephalitis Virus Vaccine Sales Market Share by Region (2018-2029)
2.5 US & Canada
2.6 Europe
2.7 China
2.8 Asia (excluding China)
2.9 Middle East, Africa and Latin America
3 Competition by Manufactures
3.1 Global Japanese Encephalitis Virus Vaccine Sales by Manufacturers
3.1.1 Global Japanese Encephalitis Virus Vaccine Sales by Manufacturers (2018-2024)
3.1.2 Global Japanese Encephalitis Virus Vaccine Sales Market Share by Manufacturers (2018-2024)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Japanese Encephalitis Virus Vaccine in 2022
3.2 Global Japanese Encephalitis Virus Vaccine Revenue by Manufacturers
3.2.1 Global Japanese Encephalitis Virus Vaccine Revenue by Manufacturers (2018-2024)
3.2.2 Global Japanese Encephalitis Virus Vaccine Revenue Market Share by Manufacturers (2018-2024)
3.2.3 Global Top 10 and Top 5 Companies by Japanese Encephalitis Virus Vaccine Revenue in 2022
3.3 Global Key Players of Japanese Encephalitis Virus Vaccine, Industry Ranking, 2021 VS 2022 VS 2024
3.4 Global Japanese Encephalitis Virus Vaccine Sales Price by Manufacturers
3.5 Analysis of Competitive Landscape
3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.5.2 Global Japanese Encephalitis Virus Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Key Manufacturers of Japanese Encephalitis Virus Vaccine, Manufacturing Base Distribution and Headquarters
3.7 Global Key Manufacturers of Japanese Encephalitis Virus Vaccine, Product Offered and Application
3.8 Global Key Manufacturers of Japanese Encephalitis Virus Vaccine, Date of Enter into This Industry
3.9 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Japanese Encephalitis Virus Vaccine Sales by Type
4.1.1 Global Japanese Encephalitis Virus Vaccine Historical Sales by Type (2018-2024)
4.1.2 Global Japanese Encephalitis Virus Vaccine Forecasted Sales by Type (2024-2029)
4.1.3 Global Japanese Encephalitis Virus Vaccine Sales Market Share by Type (2018-2029)
4.2 Global Japanese Encephalitis Virus Vaccine Revenue by Type
4.2.1 Global Japanese Encephalitis Virus Vaccine Historical Revenue by Type (2018-2024)
4.2.2 Global Japanese Encephalitis Virus Vaccine Forecasted Revenue by Type (2024-2029)
4.2.3 Global Japanese Encephalitis Virus Vaccine Revenue Market Share by Type (2018-2029)
4.3 Global Japanese Encephalitis Virus Vaccine Price by Type
4.3.1 Global Japanese Encephalitis Virus Vaccine Price by Type (2018-2024)
4.3.2 Global Japanese Encephalitis Virus Vaccine Price Forecast by Type (2024-2029)
5 Market Size by Application
5.1 Global Japanese Encephalitis Virus Vaccine Sales by Application
5.1.1 Global Japanese Encephalitis Virus Vaccine Historical Sales by Application (2018-2024)
5.1.2 Global Japanese Encephalitis Virus Vaccine Forecasted Sales by Application (2024-2029)
5.1.3 Global Japanese Encephalitis Virus Vaccine Sales Market Share by Application (2018-2029)
5.2 Global Japanese Encephalitis Virus Vaccine Revenue by Application
5.2.1 Global Japanese Encephalitis Virus Vaccine Historical Revenue by Application (2018-2024)
5.2.2 Global Japanese Encephalitis Virus Vaccine Forecasted Revenue by Application (2024-2029)
5.2.3 Global Japanese Encephalitis Virus Vaccine Revenue Market Share by Application (2018-2029)
5.3 Global Japanese Encephalitis Virus Vaccine Price by Application
5.3.1 Global Japanese Encephalitis Virus Vaccine Price by Application (2018-2024)
5.3.2 Global Japanese Encephalitis Virus Vaccine Price Forecast by Application (2024-2029)
6 US & Canada
6.1 US & Canada Japanese Encephalitis Virus Vaccine Market Size by Type
6.1.1 US & Canada Japanese Encephalitis Virus Vaccine Sales by Type (2018-2029)
6.1.2 US & Canada Japanese Encephalitis Virus Vaccine Revenue by Type (2018-2029)
6.2 US & Canada Japanese Encephalitis Virus Vaccine Market Size by Application
6.2.1 US & Canada Japanese Encephalitis Virus Vaccine Sales by Application (2018-2029)
6.2.2 US & Canada Japanese Encephalitis Virus Vaccine Revenue by Application (2018-2029)
6.3 US & Canada Japanese Encephalitis Virus Vaccine Market Size by Country
6.3.1 US & Canada Japanese Encephalitis Virus Vaccine Revenue by Country: 2018 VS 2022 VS 2029
6.3.2 US & Canada Japanese Encephalitis Virus Vaccine Sales by Country (2018-2029)
6.3.3 US & Canada Japanese Encephalitis Virus Vaccine Revenue by Country (2018-2029)
6.3.4 US
6.3.5 Canada
7 Europe
7.1 Europe Japanese Encephalitis Virus Vaccine Market Size by Type
7.1.1 Europe Japanese Encephalitis Virus Vaccine Sales by Type (2018-2029)
7.1.2 Europe Japanese Encephalitis Virus Vaccine Revenue by Type (2018-2029)
7.2 Europe Japanese Encephalitis Virus Vaccine Market Size by Application
7.2.1 Europe Japanese Encephalitis Virus Vaccine Sales by Application (2018-2029)
7.2.2 Europe Japanese Encephalitis Virus Vaccine Revenue by Application (2018-2029)
7.3 Europe Japanese Encephalitis Virus Vaccine Market Size by Country
7.3.1 Europe Japanese Encephalitis Virus Vaccine Revenue by Country: 2018 VS 2022 VS 2029
7.3.2 Europe Japanese Encephalitis Virus Vaccine Sales by Country (2018-2029)
7.3.3 Europe Japanese Encephalitis Virus Vaccine Revenue by Country (2018-2029)
7.3.4 Germany
7.3.5 France
7.3.6 UK
7.3.7 Italy
7.3.8 Russia
8 China
8.1 China Japanese Encephalitis Virus Vaccine Market Size
8.1.1 China Japanese Encephalitis Virus Vaccine Sales (2018-2029)
8.1.2 China Japanese Encephalitis Virus Vaccine Revenue (2018-2029)
8.2 China Japanese Encephalitis Virus Vaccine Market Size by Application
8.2.1 China Japanese Encephalitis Virus Vaccine Sales by Application (2018-2029)
8.2.2 China Japanese Encephalitis Virus Vaccine Revenue by Application (2018-2029)
9 Asia (excluding China)
9.1 Asia Japanese Encephalitis Virus Vaccine Market Size by Type
9.1.1 Asia Japanese Encephalitis Virus Vaccine Sales by Type (2018-2029)
9.1.2 Asia Japanese Encephalitis Virus Vaccine Revenue by Type (2018-2029)
9.2 Asia Japanese Encephalitis Virus Vaccine Market Size by Application
9.2.1 Asia Japanese Encephalitis Virus Vaccine Sales by Application (2018-2029)
9.2.2 Asia Japanese Encephalitis Virus Vaccine Revenue by Application (2018-2029)
9.3 Asia Japanese Encephalitis Virus Vaccine Sales by Region
9.3.1 Asia Japanese Encephalitis Virus Vaccine Revenue by Region: 2018 VS 2022 VS 2029
9.3.2 Asia Japanese Encephalitis Virus Vaccine Revenue by Region (2018-2029)
9.3.3 Asia Japanese Encephalitis Virus Vaccine Sales by Region (2018-2029)
9.3.4 Japan
9.3.5 South Korea
9.3.6 China Taiwan
9.3.7 Southeast Asia
9.3.8 India
10 Middle East, Africa and Latin America
10.1 Middle East, Africa and Latin America Japanese Encephalitis Virus Vaccine Market Size by Type
10.1.1 Middle East, Africa and Latin America Japanese Encephalitis Virus Vaccine Sales by Type (2018-2029)
10.1.2 Middle East, Africa and Latin America Japanese Encephalitis Virus Vaccine Revenue by Type (2018-2029)
10.2 Middle East, Africa and Latin America Japanese Encephalitis Virus Vaccine Market Size by Application
10.2.1 Middle East, Africa and Latin America Japanese Encephalitis Virus Vaccine Sales by Application (2018-2029)
10.2.2 Middle East, Africa and Latin America Japanese Encephalitis Virus Vaccine Revenue by Application (2018-2029)
10.3 Middle East, Africa and Latin America Japanese Encephalitis Virus Vaccine Sales by Country
10.3.1 Middle East, Africa and Latin America Japanese Encephalitis Virus Vaccine Revenue by Country: 2018 VS 2022 VS 2029
10.3.2 Middle East, Africa and Latin America Japanese Encephalitis Virus Vaccine Revenue by Country (2018-2029)
10.3.3 Middle East, Africa and Latin America Japanese Encephalitis Virus Vaccine Sales by Country (2018-2029)
10.3.4 Brazil
10.3.5 Mexico
10.3.6 Turkey
10.3.7 Israel
10.3.8 GCC Countries
11 Company Profiles
11.1 Research Foundation for Microbial Diseases of Osaka University
11.1.1 Research Foundation for Microbial Diseases of Osaka University Company Information
11.1.2 Research Foundation for Microbial Diseases of Osaka University Overview
11.1.3 Research Foundation for Microbial Diseases of Osaka University Japanese Encephalitis Virus Vaccine Sales, Price, Revenue and Gross Margin (2018-2024)
11.1.4 Research Foundation for Microbial Diseases of Osaka University Japanese Encephalitis Virus Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Research Foundation for Microbial Diseases of Osaka University Recent Developments
11.2 Valneva Austria GmbH
11.2.1 Valneva Austria GmbH Company Information
11.2.2 Valneva Austria GmbH Overview
11.2.3 Valneva Austria GmbH Japanese Encephalitis Virus Vaccine Sales, Price, Revenue and Gross Margin (2018-2024)
11.2.4 Valneva Austria GmbH Japanese Encephalitis Virus Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Valneva Austria GmbH Recent Developments
11.3 Chengdu Institute
11.3.1 Chengdu Institute Company Information
11.3.2 Chengdu Institute Overview
11.3.3 Chengdu Institute Japanese Encephalitis Virus Vaccine Sales, Price, Revenue and Gross Margin (2018-2024)
11.3.4 Chengdu Institute Japanese Encephalitis Virus Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Chengdu Institute Recent Developments
11.4 Liaoning Dacheng
11.4.1 Liaoning Dacheng Company Information
11.4.2 Liaoning Dacheng Overview
11.4.3 Liaoning Dacheng Japanese Encephalitis Virus Vaccine Sales, Price, Revenue and Gross Margin (2018-2024)
11.4.4 Liaoning Dacheng Japanese Encephalitis Virus Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Liaoning Dacheng Recent Developments
11.5 Wuhan Institute
11.5.1 Wuhan Institute Company Information
11.5.2 Wuhan Institute Overview
11.5.3 Wuhan Institute Japanese Encephalitis Virus Vaccine Sales, Price, Revenue and Gross Margin (2018-2024)
11.5.4 Wuhan Institute Japanese Encephalitis Virus Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Wuhan Institute Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Japanese Encephalitis Virus Vaccine Industry Chain Analysis
12.2 Japanese Encephalitis Virus Vaccine Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Japanese Encephalitis Virus Vaccine Production Mode & Process
12.4 Japanese Encephalitis Virus Vaccine Sales and Marketing
12.4.1 Japanese Encephalitis Virus Vaccine Sales Channels
12.4.2 Japanese Encephalitis Virus Vaccine Distributors
12.5 Japanese Encephalitis Virus Vaccine Customers
13 Market Dynamics
13.1 Japanese Encephalitis Virus Vaccine Industry Trends
13.2 Japanese Encephalitis Virus Vaccine Market Drivers
13.3 Japanese Encephalitis Virus Vaccine Market Challenges
13.4 Japanese Encephalitis Virus Vaccine Market Restraints
14 Key Findings in The Global Japanese Encephalitis Virus Vaccine Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer

List of Figure

List of Tables
Table 1. Global Japanese Encephalitis Virus Vaccine Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
Table 2. Major Manufacturers of Inactivated Vaccine
Table 3. Major Manufacturers of Live Attenuated Vaccine
Table 4. Global Japanese Encephalitis Virus Vaccine Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
Table 5. Global Japanese Encephalitis Virus Vaccine Revenue Grow Rate (CAGR) by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 6. Global Japanese Encephalitis Virus Vaccine Revenue by Region (2018-2024) & (US$ Million)
Table 7. Global Japanese Encephalitis Virus Vaccine Revenue by Region (2024-2029) & (US$ Million)
Table 8. Global Japanese Encephalitis Virus Vaccine Revenue Market Share by Region (2018-2024)
Table 9. Global Japanese Encephalitis Virus Vaccine Revenue Market Share by Region (2024-2029)
Table 10. Global Japanese Encephalitis Virus Vaccine Sales Grow Rate (CAGR) by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 11. Global Japanese Encephalitis Virus Vaccine Sales by Region (2018-2024) & (K Units)
Table 12. Global Japanese Encephalitis Virus Vaccine Sales by Region (2024-2029) & (K Units)
Table 13. Global Japanese Encephalitis Virus Vaccine Sales Market Share by Region (2018-2024)
Table 14. Global Japanese Encephalitis Virus Vaccine Sales Market Share by Region (2024-2029)
Table 15. Global Japanese Encephalitis Virus Vaccine Sales by Manufacturers (2018-2024) & (K Units)
Table 16. Global Japanese Encephalitis Virus Vaccine Sales Share by Manufacturers (2018-2024)
Table 17. Global Japanese Encephalitis Virus Vaccine Revenue by Manufacturers (2018-2024) & (US$ Million)
Table 18. Global Japanese Encephalitis Virus Vaccine Revenue Share by Manufacturers (2018-2024)
Table 19. Global Key Players of Japanese Encephalitis Virus Vaccine, Industry Ranking, 2021 VS 2022 VS 2024
Table 20. Japanese Encephalitis Virus Vaccine Price by Manufacturers 2018-2024 (USD/Unit)
Table 21. Global Japanese Encephalitis Virus Vaccine Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 22. Global Japanese Encephalitis Virus Vaccine by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Japanese Encephalitis Virus Vaccine as of 2022)
Table 23. Global Key Manufacturers of Japanese Encephalitis Virus Vaccine, Manufacturing Base Distribution and Headquarters
Table 24. Global Key Manufacturers of Japanese Encephalitis Virus Vaccine, Product Offered and Application
Table 25. Global Key Manufacturers of Japanese Encephalitis Virus Vaccine, Date of Enter into This Industry
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global Japanese Encephalitis Virus Vaccine Sales by Type (2018-2024) & (K Units)
Table 28. Global Japanese Encephalitis Virus Vaccine Sales by Type (2024-2029) & (K Units)
Table 29. Global Japanese Encephalitis Virus Vaccine Sales Share by Type (2018-2024)
Table 30. Global Japanese Encephalitis Virus Vaccine Sales Share by Type (2024-2029)
Table 31. Global Japanese Encephalitis Virus Vaccine Revenue by Type (2018-2024) & (US$ Million)
Table 32. Global Japanese Encephalitis Virus Vaccine Revenue by Type (2024-2029) & (US$ Million)
Table 33. Global Japanese Encephalitis Virus Vaccine Revenue Share by Type (2018-2024)
Table 34. Global Japanese Encephalitis Virus Vaccine Revenue Share by Type (2024-2029)
Table 35. Japanese Encephalitis Virus Vaccine Price by Type (2018-2024) & (USD/Unit)
Table 36. Global Japanese Encephalitis Virus Vaccine Price Forecast by Type (2024-2029) & (USD/Unit)
Table 37. Global Japanese Encephalitis Virus Vaccine Sales by Application (2018-2024) & (K Units)
Table 38. Global Japanese Encephalitis Virus Vaccine Sales by Application (2024-2029) & (K Units)
Table 39. Global Japanese Encephalitis Virus Vaccine Sales Share by Application (2018-2024)
Table 40. Global Japanese Encephalitis Virus Vaccine Sales Share by Application (2024-2029)
Table 41. Global Japanese Encephalitis Virus Vaccine Revenue by Application (2018-2024) & (US$ Million)
Table 42. Global Japanese Encephalitis Virus Vaccine Revenue by Application (2024-2029) & (US$ Million)
Table 43. Global Japanese Encephalitis Virus Vaccine Revenue Share by Application (2018-2024)
Table 44. Global Japanese Encephalitis Virus Vaccine Revenue Share by Application (2024-2029)
Table 45. Japanese Encephalitis Virus Vaccine Price by Application (2018-2024) & (USD/Unit)
Table 46. Global Japanese Encephalitis Virus Vaccine Price Forecast by Application (2024-2029) & (USD/Unit)
Table 47. US & Canada Japanese Encephalitis Virus Vaccine Sales by Type (2018-2024) & (K Units)
Table 48. US & Canada Japanese Encephalitis Virus Vaccine Sales by Type (2024-2029) & (K Units)
Table 49. US & Canada Japanese Encephalitis Virus Vaccine Revenue by Type (2018-2024) & (US$ Million)
Table 50. US & Canada Japanese Encephalitis Virus Vaccine Revenue by Type (2024-2029) & (US$ Million)
Table 51. US & Canada Japanese Encephalitis Virus Vaccine Sales by Application (2018-2024) & (K Units)
Table 52. US & Canada Japanese Encephalitis Virus Vaccine Sales by Application (2024-2029) & (K Units)
Table 53. US & Canada Japanese Encephalitis Virus Vaccine Revenue by Application (2018-2024) & (US$ Million)
Table 54. US & Canada Japanese Encephalitis Virus Vaccine Revenue by Application (2024-2029) & (US$ Million)
Table 55. US & Canada Japanese Encephalitis Virus Vaccine Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 56. US & Canada Japanese Encephalitis Virus Vaccine Revenue by Country (2018-2024) & (US$ Million)
Table 57. US & Canada Japanese Encephalitis Virus Vaccine Revenue by Country (2024-2029) & (US$ Million)
Table 58. US & Canada Japanese Encephalitis Virus Vaccine Sales by Country (2018-2024) & (K Units)
Table 59. US & Canada Japanese Encephalitis Virus Vaccine Sales by Country (2024-2029) & (K Units)
Table 60. Europe Japanese Encephalitis Virus Vaccine Sales by Type (2018-2024) & (K Units)
Table 61. Europe Japanese Encephalitis Virus Vaccine Sales by Type (2024-2029) & (K Units)
Table 62. Europe Japanese Encephalitis Virus Vaccine Revenue by Type (2018-2024) & (US$ Million)
Table 63. Europe Japanese Encephalitis Virus Vaccine Revenue by Type (2024-2029) & (US$ Million)
Table 64. Europe Japanese Encephalitis Virus Vaccine Sales by Application (2018-2024) & (K Units)
Table 65. Europe Japanese Encephalitis Virus Vaccine Sales by Application (2024-2029) & (K Units)
Table 66. Europe Japanese Encephalitis Virus Vaccine Revenue by Application (2018-2024) & (US$ Million)
Table 67. Europe Japanese Encephalitis Virus Vaccine Revenue by Application (2024-2029) & (US$ Million)
Table 68. Europe Japanese Encephalitis Virus Vaccine Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 69. Europe Japanese Encephalitis Virus Vaccine Revenue by Country (2018-2024) & (US$ Million)
Table 70. Europe Japanese Encephalitis Virus Vaccine Revenue by Country (2024-2029) & (US$ Million)
Table 71. Europe Japanese Encephalitis Virus Vaccine Sales by Country (2018-2024) & (K Units)
Table 72. Europe Japanese Encephalitis Virus Vaccine Sales by Country (2024-2029) & (K Units)
Table 73. China Japanese Encephalitis Virus Vaccine Sales by Type (2018-2024) & (K Units)
Table 74. China Japanese Encephalitis Virus Vaccine Sales by Type (2024-2029) & (K Units)
Table 75. China Japanese Encephalitis Virus Vaccine Revenue by Type (2018-2024) & (US$ Million)
Table 76. China Japanese Encephalitis Virus Vaccine Revenue by Type (2024-2029) & (US$ Million)
Table 77. China Japanese Encephalitis Virus Vaccine Sales by Application (2018-2024) & (K Units)
Table 78. China Japanese Encephalitis Virus Vaccine Sales by Application (2024-2029) & (K Units)
Table 79. China Japanese Encephalitis Virus Vaccine Revenue by Application (2018-2024) & (US$ Million)
Table 80. China Japanese Encephalitis Virus Vaccine Revenue by Application (2024-2029) & (US$ Million)
Table 81. Asia Japanese Encephalitis Virus Vaccine Sales by Type (2018-2024) & (K Units)
Table 82. Asia Japanese Encephalitis Virus Vaccine Sales by Type (2024-2029) & (K Units)
Table 83. Asia Japanese Encephalitis Virus Vaccine Revenue by Type (2018-2024) & (US$ Million)
Table 84. Asia Japanese Encephalitis Virus Vaccine Revenue by Type (2024-2029) & (US$ Million)
Table 85. Asia Japanese Encephalitis Virus Vaccine Sales by Application (2018-2024) & (K Units)
Table 86. Asia Japanese Encephalitis Virus Vaccine Sales by Application (2024-2029) & (K Units)
Table 87. Asia Japanese Encephalitis Virus Vaccine Revenue by Application (2018-2024) & (US$ Million)
Table 88. Asia Japanese Encephalitis Virus Vaccine Revenue by Application (2024-2029) & (US$ Million)
Table 89. Asia Japanese Encephalitis Virus Vaccine Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 90. Asia Japanese Encephalitis Virus Vaccine Revenue by Region (2018-2024) & (US$ Million)
Table 91. Asia Japanese Encephalitis Virus Vaccine Revenue by Region (2024-2029) & (US$ Million)
Table 92. Asia Japanese Encephalitis Virus Vaccine Sales by Region (2018-2024) & (K Units)
Table 93. Asia Japanese Encephalitis Virus Vaccine Sales by Region (2024-2029) & (K Units)
Table 94. Middle East, Africa and Latin America Japanese Encephalitis Virus Vaccine Sales by Type (2018-2024) & (K Units)
Table 95. Middle East, Africa and Latin America Japanese Encephalitis Virus Vaccine Sales by Type (2024-2029) & (K Units)
Table 96. Middle East, Africa and Latin America Japanese Encephalitis Virus Vaccine Revenue by Type (2018-2024) & (US$ Million)
Table 97. Middle East, Africa and Latin America Japanese Encephalitis Virus Vaccine Revenue by Type (2024-2029) & (US$ Million)
Table 98. Middle East, Africa and Latin America Japanese Encephalitis Virus Vaccine Sales by Application (2018-2024) & (K Units)
Table 99. Middle East, Africa and Latin America Japanese Encephalitis Virus Vaccine Sales by Application (2024-2029) & (K Units)
Table 100. Middle East, Africa and Latin America Japanese Encephalitis Virus Vaccine Revenue by Application (2018-2024) & (US$ Million)
Table 101. Middle East, Africa and Latin America Japanese Encephalitis Virus Vaccine Revenue by Application (2024-2029) & (US$ Million)
Table 102. Middle East, Africa and Latin America Japanese Encephalitis Virus Vaccine Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 103. Middle East, Africa and Latin America Japanese Encephalitis Virus Vaccine Revenue by Country (2018-2024) & (US$ Million)
Table 104. Middle East, Africa and Latin America Japanese Encephalitis Virus Vaccine Revenue by Country (2024-2029) & (US$ Million)
Table 105. Middle East, Africa and Latin America Japanese Encephalitis Virus Vaccine Sales by Country (2018-2024) & (K Units)
Table 106. Middle East, Africa and Latin America Japanese Encephalitis Virus Vaccine Sales by Country (2024-2029) & (K Units)
Table 107. Research Foundation for Microbial Diseases of Osaka University Company Information
Table 108. Research Foundation for Microbial Diseases of Osaka University Description and Major Businesses
Table 109. Research Foundation for Microbial Diseases of Osaka University Japanese Encephalitis Virus Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 110. Research Foundation for Microbial Diseases of Osaka University Japanese Encephalitis Virus Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
Table 111. Research Foundation for Microbial Diseases of Osaka University Recent Developments
Table 112. Valneva Austria GmbH Company Information
Table 113. Valneva Austria GmbH Description and Major Businesses
Table 114. Valneva Austria GmbH Japanese Encephalitis Virus Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 115. Valneva Austria GmbH Japanese Encephalitis Virus Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
Table 116. Valneva Austria GmbH Recent Developments
Table 117. Chengdu Institute Company Information
Table 118. Chengdu Institute Description and Major Businesses
Table 119. Chengdu Institute Japanese Encephalitis Virus Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 120. Chengdu Institute Japanese Encephalitis Virus Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
Table 121. Chengdu Institute Recent Developments
Table 122. Liaoning Dacheng Company Information
Table 123. Liaoning Dacheng Description and Major Businesses
Table 124. Liaoning Dacheng Japanese Encephalitis Virus Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 125. Liaoning Dacheng Japanese Encephalitis Virus Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
Table 126. Liaoning Dacheng Recent Developments
Table 127. Wuhan Institute Company Information
Table 128. Wuhan Institute Description and Major Businesses
Table 129. Wuhan Institute Japanese Encephalitis Virus Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 130. Wuhan Institute Japanese Encephalitis Virus Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
Table 131. Wuhan Institute Recent Developments
Table 132. Key Raw Materials Lists
Table 133. Raw Materials Key Suppliers Lists
Table 134. Japanese Encephalitis Virus Vaccine Distributors List
Table 135. Japanese Encephalitis Virus Vaccine Customers List
Table 136. Japanese Encephalitis Virus Vaccine Market Trends
Table 137. Japanese Encephalitis Virus Vaccine Market Drivers
Table 138. Japanese Encephalitis Virus Vaccine Market Challenges
Table 139. Japanese Encephalitis Virus Vaccine Market Restraints
Table 140. Research Programs/Design for This Report
Table 141. Key Data Information from Secondary Sources
Table 142. Key Data Information from Primary Sources
List of Figures
Figure 1. Japanese Encephalitis Virus Vaccine Product Picture
Figure 2. Global Japanese Encephalitis Virus Vaccine Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
Figure 3. Global Japanese Encephalitis Virus Vaccine Market Share by Type in 2022 & 2029
Figure 4. Inactivated Vaccine Product Picture
Figure 5. Live Attenuated Vaccine Product Picture
Figure 6. Global Japanese Encephalitis Virus Vaccine Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
Figure 7. Global Japanese Encephalitis Virus Vaccine Market Share by Application in 2022 & 2029
Figure 8. Public
Figure 9. Private
Figure 10. Japanese Encephalitis Virus Vaccine Report Years Considered
Figure 11. Global Japanese Encephalitis Virus Vaccine Revenue, (US$ Million), 2018 VS 2022 VS 2029
Figure 12. Global Japanese Encephalitis Virus Vaccine Revenue 2018-2029 (US$ Million)
Figure 13. Global Japanese Encephalitis Virus Vaccine Revenue Market Share by Region in Percentage: 2022 Versus 2029
Figure 14. Global Japanese Encephalitis Virus Vaccine Revenue Market Share by Region (2018-2029)
Figure 15. Global Japanese Encephalitis Virus Vaccine Sales 2018-2029 ((K Units)
Figure 16. Global Japanese Encephalitis Virus Vaccine Sales Market Share by Region (2018-2029)
Figure 17. US & Canada Japanese Encephalitis Virus Vaccine Sales YoY (2018-2029) & (K Units)
Figure 18. US & Canada Japanese Encephalitis Virus Vaccine Revenue YoY (2018-2029) & (US$ Million)
Figure 19. Europe Japanese Encephalitis Virus Vaccine Sales YoY (2018-2029) & (K Units)
Figure 20. Europe Japanese Encephalitis Virus Vaccine Revenue YoY (2018-2029) & (US$ Million)
Figure 21. China Japanese Encephalitis Virus Vaccine Sales YoY (2018-2029) & (K Units)
Figure 22. China Japanese Encephalitis Virus Vaccine Revenue YoY (2018-2029) & (US$ Million)
Figure 23. Asia (excluding China) Japanese Encephalitis Virus Vaccine Sales YoY (2018-2029) & (K Units)
Figure 24. Asia (excluding China) Japanese Encephalitis Virus Vaccine Revenue YoY (2018-2029) & (US$ Million)
Figure 25. Middle East, Africa and Latin America Japanese Encephalitis Virus Vaccine Sales YoY (2018-2029) & (K Units)
Figure 26. Middle East, Africa and Latin America Japanese Encephalitis Virus Vaccine Revenue YoY (2018-2029) & (US$ Million)
Figure 27. The Japanese Encephalitis Virus Vaccine Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2022
Figure 28. The Top 5 and 10 Largest Manufacturers of Japanese Encephalitis Virus Vaccine in the World: Market Share by Japanese Encephalitis Virus Vaccine Revenue in 2022
Figure 29. Global Japanese Encephalitis Virus Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 30. Global Japanese Encephalitis Virus Vaccine Sales Market Share by Type (2018-2029)
Figure 31. Global Japanese Encephalitis Virus Vaccine Revenue Market Share by Type (2018-2029)
Figure 32. Global Japanese Encephalitis Virus Vaccine Sales Market Share by Application (2018-2029)
Figure 33. Global Japanese Encephalitis Virus Vaccine Revenue Market Share by Application (2018-2029)
Figure 34. US & Canada Japanese Encephalitis Virus Vaccine Sales Market Share by Type (2018-2029)
Figure 35. US & Canada Japanese Encephalitis Virus Vaccine Revenue Market Share by Type (2018-2029)
Figure 36. US & Canada Japanese Encephalitis Virus Vaccine Sales Market Share by Application (2018-2029)
Figure 37. US & Canada Japanese Encephalitis Virus Vaccine Revenue Market Share by Application (2018-2029)
Figure 38. US & Canada Japanese Encephalitis Virus Vaccine Revenue Share by Country (2018-2029)
Figure 39. US & Canada Japanese Encephalitis Virus Vaccine Sales Share by Country (2018-2029)
Figure 40. U.S. Japanese Encephalitis Virus Vaccine Revenue (2018-2029) & (US$ Million)
Figure 41. Canada Japanese Encephalitis Virus Vaccine Revenue (2018-2029) & (US$ Million)
Figure 42. Europe Japanese Encephalitis Virus Vaccine Sales Market Share by Type (2018-2029)
Figure 43. Europe Japanese Encephalitis Virus Vaccine Revenue Market Share by Type (2018-2029)
Figure 44. Europe Japanese Encephalitis Virus Vaccine Sales Market Share by Application (2018-2029)
Figure 45. Europe Japanese Encephalitis Virus Vaccine Revenue Market Share by Application (2018-2029)
Figure 46. Europe Japanese Encephalitis Virus Vaccine Revenue Share by Country (2018-2029)
Figure 47. Europe Japanese Encephalitis Virus Vaccine Sales Share by Country (2018-2029)
Figure 48. Germany Japanese Encephalitis Virus Vaccine Revenue (2018-2029) & (US$ Million)
Figure 49. France Japanese Encephalitis Virus Vaccine Revenue (2018-2029) & (US$ Million)
Figure 50. UK Japanese Encephalitis Virus Vaccine Revenue (2018-2029) & (US$ Million)
Figure 51. Italy Japanese Encephalitis Virus Vaccine Revenue (2018-2029) & (US$ Million)
Figure 52. Russia Japanese Encephalitis Virus Vaccine Revenue (2018-2029) & (US$ Million)
Figure 53. China Japanese Encephalitis Virus Vaccine Sales Market Share by Type (2018-2029)
Figure 54. China Japanese Encephalitis Virus Vaccine Revenue Market Share by Type (2018-2029)
Figure 55. China Japanese Encephalitis Virus Vaccine Sales Market Share by Application (2018-2029)
Figure 56. China Japanese Encephalitis Virus Vaccine Revenue Market Share by Application (2018-2029)
Figure 57. Asia Japanese Encephalitis Virus Vaccine Sales Market Share by Type (2018-2029)
Figure 58. Asia Japanese Encephalitis Virus Vaccine Revenue Market Share by Type (2018-2029)
Figure 59. Asia Japanese Encephalitis Virus Vaccine Sales Market Share by Application (2018-2029)
Figure 60. Asia Japanese Encephalitis Virus Vaccine Revenue Market Share by Application (2018-2029)
Figure 61. Asia Japanese Encephalitis Virus Vaccine Revenue Share by Region (2018-2029)
Figure 62. Asia Japanese Encephalitis Virus Vaccine Sales Share by Region (2018-2029)
Figure 63. Japan Japanese Encephalitis Virus Vaccine Revenue (2018-2029) & (US$ Million)
Figure 64. South Korea Japanese Encephalitis Virus Vaccine Revenue (2018-2029) & (US$ Million)
Figure 65. China Taiwan Japanese Encephalitis Virus Vaccine Revenue (2018-2029) & (US$ Million)
Figure 66. Southeast Asia Japanese Encephalitis Virus Vaccine Revenue (2018-2029) & (US$ Million)
Figure 67. India Japanese Encephalitis Virus Vaccine Revenue (2018-2029) & (US$ Million)
Figure 68. Middle East, Africa and Latin America Japanese Encephalitis Virus Vaccine Sales Market Share by Type (2018-2029)
Figure 69. Middle East, Africa and Latin America Japanese Encephalitis Virus Vaccine Revenue Market Share by Type (2018-2029)
Figure 70. Middle East, Africa and Latin America Japanese Encephalitis Virus Vaccine Sales Market Share by Application (2018-2029)
Figure 71. Middle East, Africa and Latin America Japanese Encephalitis Virus Vaccine Revenue Market Share by Application (2018-2029)
Figure 72. Middle East, Africa and Latin America Japanese Encephalitis Virus Vaccine Revenue Share by Country (2018-2029)
Figure 73. Middle East, Africa and Latin America Japanese Encephalitis Virus Vaccine Sales Share by Country (2018-2029)
Figure 74. Brazil Japanese Encephalitis Virus Vaccine Revenue (2018-2029) & (US$ Million)
Figure 75. Mexico Japanese Encephalitis Virus Vaccine Revenue (2018-2029) & (US$ Million)
Figure 76. Turkey Japanese Encephalitis Virus Vaccine Revenue (2018-2029) & (US$ Million)
Figure 77. Israel Japanese Encephalitis Virus Vaccine Revenue (2018-2029) & (US$ Million)
Figure 78. GCC Countries Japanese Encephalitis Virus Vaccine Revenue (2018-2029) & (US$ Million)
Figure 79. Japanese Encephalitis Virus Vaccine Value Chain
Figure 80. Japanese Encephalitis Virus Vaccine Production Process
Figure 81. Channels of Distribution
Figure 82. Distributors Profiles
Figure 83. Bottom-up and Top-down Approaches for This Report
Figure 84. Data Triangulation
Figure 85. Key Executives Interviewed

Select User License

$4200 Single Licence
$6000 Enterprise Licence
$9100 Corporate Licence
Note : All prices in USD

FAQ'S

User License?

For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:

sales@mraccuracyreports.com

Within 24 to 48 hrs.

You can contact Sales team (sales@mraccuracyreports.com) and they will direct you on email

You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.

Discounts are available.

Hard Copy

Email

Top Industries